Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease through percutaneous cardiovascular interventions.
Improving the quality of life and reducing sudden cardiac death by limiting the impact of heart rhythm disturbances.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
In 2016, during the Working Group’s General Assembly at the ESC Congresss, 5 awards have been given to the first authors / presenters of the best graded abstracts on Venous Thromboembolism and Pulmonary Hypertension.
Stavros Konstantinides, Sabina Rosset, Kenzo Ichimura, Max-Paul Winter, Mona Sahlholdt Hansen, Irene Lang [left to right]
Erik Klok (Vienna, AT), for its abstract on Acute Pulmonary EmbolismPrediction of bleeding events in patients with venous thromboembolism on stable anticoagulationMona Sahlholdt Hansen (Aarhus N, DK), for its abstract on Right Ventricular Function Levosimendan prevents and reverts pressure-overload induced right ventricular failureMax-Paul Winter (Vienna, AT), for its abstract on Chronic Pulmonary HypertensionA new experimental model of pulmonary arterial hypertension- KDR knock outKenzo Ichimura (Fukuoka, JP), for its abstract on Chronic Pulmonary HypertensionNanoparticle-mediated targeting of pitavastatin into small pulmonary arteries by intravenous administration attenuates the progression of monocrotaline-induced pulmonary arterial hypertension in ratsSabina Rosset (Lausanne,CH), for its abstract on Chronic Pulmonary HypertensionSevere ventricular interdependence as a cause of misclassification of group 2 pulmonary hypertension
Mario Gerges (Vienna,AT) for its abstract on Right ventricular function:Combined pre and post-capillary pulmonary hypertension in chronic heart failure: epidemiology, right ventricular function and survival
Erik Klok (Leiden,NL) for its abstract on Acute pulmonary embolismWithholding anticoagulation after negative CTPA is safe in patients with a likely clinical probability of PE
Hideya Shigyo (Suita,JP) for its abstract on Pulmonary circulationEfficacy and safety of first-line oral triple upfront combination therapy in severe pulmonary arterial hypertension patients
Kasper Hasseriis Andersen (Copenhagen,DK) for its abstract on Chronic pulmonary hypertensionVenous remodelling in COPD pulmonary hypertension and idiopathic pulmonary arterial hypertension
Yaguo Zheng: Oral targeted therapies in the treatment of pulmonary arterial hypertension: a meta-analysis of clinical trialsChristian Gerges: Pulmonary artery occlusion waveform analysis for the assessment of pulmonary vascular disease in pulmonary hypertension due to left heart disease Guido Claessen: Sildenafil increases stroke volume during exercise in patients with chronic thromboembolic pulmonary hypertensionAna Garcia-Alvarez: Long-term oral B3-agonist treatment reduces pulmonary vascular resistance and improves right ventricular function in a swine model of chronic postcapillary pulmonary hypertension
Erik Klok: Performance of five different bleeding-prediction scores in patients with acute pulmonary embolism Anja Kaeberich: Optimized high sensitive troponin T cut-off values for risk stratification of normotensive patients with pulmonary embolism
Delphine Baudouy: B blood type is a strong risk factor for venous thromboembolism recurrenceMareike Lankeit: Angiopoietin-2 - a novel biomarker for risk stratification of acute pulmonary embolism
Max-Paul Winter: Formation of typical vascular lesions in a new experimental model of pulmonary arterial hypertensionJose Manuel Montero Cabezas: Demythologizing pulmonary artery aneurysm: prevalence and associated complications in a large pulmonary arterial hypertension population
Abstract: Plasma MR-proADM is superior to NT-proBNP for all-cause short term mortality prediction in acute pulmonary embolismby Justyna Pedowska-WloszekAbstract: Pulmonary embolism in Sweden, a national cohort and survival analysis, by Therese AndersonAbstract: Right ventricular hypertrophy and failure abolish cardioprotection by ischemic preconditioning, by Asger AndersenAbstract: Survival in pre-capillary pulmonary hypertension: does echocardiography make the difference?, by Julia GrapsaAbstract: Egr-1 expression is specific for neointimal development in both human and experimental PAH, by Michael DickinsonAbstract: Treatment of decompensated left-sided heart failure lowers right ventricular pulsatile load and increases the pulmonary arterial time constant, by Matthias Dupont
Abstract: Pulmonary arterial stroke volume: a new and strong prognostic factor in pediatric pulmonary arterial hypertensionby Johannes Menno Douwes (NL)Abstract: Absence of influence of gender and BMPR2 mutation type on clinical phenotypes of pulmonary arterial hypertensionby Barbara Girerd (FR)Abstract: ESC-ERS 2009 pulmonary hypertension guidelines: an evaluation study in 9 European countries (the guide to PH study)by Enri Leci (IT)Abstract: Survival in patients with pulmonary arterial hypertension associated with connective tissue disease over the past decadeby Christopher Valerio (UK)Abstract: Predictive value of the new highly sensitive troponin T assay compared to a clinical score in normotensive patients with acute pulmonary embolism: a prospective external validation study by Mareike Lankeit (DE)Abstract: In-hospital major bleeding predicts mortality in patients with objectively confirmed pulmonary embolismby Anna Budaj-Fidecka (PL)
Abstract: Prognostic value of echocardiographic parameters in patients with pulmonary arterial hypertension (PAH) treated with targeted therapies, by Elena BecianiAbstract: Vardenafil in Pulmonary Arterial Hypertension: A Randomized, Double-blind, Placebo-controlled Study, by Zhi-Cheng Jing
Our mission: To reduce the burden of cardiovascular disease
© 2017 European Society of Cardiology. All rights reserved